Nationwide Fund Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-778,880
Closed -$114M 3131
2017
Q3
$114M Buy
778,880
+15,211
+2% +$2.07M 0.45% 24
2017
Q2
$99.2M Sell
763,669
-147,603
-16% -$18.1M 0.4% 29
2017
Q1
$113M Buy
911,272
+83,607
+10% +$10M 0.46% 22
2016
Q4
$95.8M Buy
827,665
+13,135
+2% +$1.46M 0.4% 25
2016
Q3
$85.1M Sell
814,530
-5,612
-0.7% -$607K 0.36% 31
2016
Q2
$80.9M Buy
820,142
+21,452
+3% +$2.22M 0.35% 33
2016
Q1
$80.6M Sell
798,690
-86,999
-10% -$8.96M 0.35% 35
2015
Q4
$106M Buy
885,689
+246,194
+38% +$28.5M 0.46% 24
2015
Q3
$69.2M Buy
639,495
+37,003
+6% +$4.59M 0.31% 45
2015
Q2
$69.7M Sell
602,492
-170,062
-22% -$19.4M 0.29% 54
2015
Q1
$89.1M Buy
772,554
+1,378
+0.2% +$165K 0.36% 35
2014
Q4
$86.3M Sell
771,176
-66,079
-8% -$6.97M 0.37% 33
2014
Q3
$79.4M Buy
837,255
+166,739
+25% +$15M 0.34% 37
2014
Q2
$57.6M Sell
670,516
-21,324
-3% -$1.62M 0.23% 72
2014
Q1
$48.3M Sell
691,840
-278,280
-29% -$22M 0.22% 85
2013
Q4
$82M Sell
970,120
-3,256
-0.3% -$258K 0.34% 38
2013
Q3
$74.9M Sell
973,376
-21,456
-2% -$1.5M 0.34% 40
2013
Q2
$58.2M Buy
+994,832
New +$59.9M 0.31% 55

Other funds holding CELG

Nationwide Fund Advisors's CELG Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 778,880 shares — an estimated $114M sold.

Nationwide Fund Advisors first reported a position in CELG in Q2 2013 and held it in 18 quarters. The position peaked at $114M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 778,880 Celgene Corp shares in Q4 2017, an estimated $114M.
  • Nationwide Fund Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Celgene Corp position peaked at $114M in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.